| Scope of Activity: | Leadership of company in co-operation with the CEO: Shaping the Strategy, Co-operation with shareholder 3i and Synergy 1, managed the business with the CEO,Leadership of Finance organization: improvement of processes and systems, providing objectives and controlling achievements, development of human capital;Management of departments: Controlling: reporting, budgeting; Investor relation: Presentations and Meetings with Investment banks and Venture Capital firms; Accounting/Payroll/Tax: Yearend and month-end closings; Electronic Data Processing/IT; Law.
Reporting line to the CEO and founder. |
| Turnover/Budget: | Start-up Biotech company, found in Feb. 1998, cost budget in 1999 3 Mio. €, in 2000 5 Mio. € |
| Projects: | 1) Preparation to float on the Neuer Markt in Frankfurt: Preparing the business plan, establishing a long-term financial planning package up to 2015, introduction of US-GAAP, Introduction of an employee stock ownership program, pre-IPO meetings with analysts and other investment banker, presentation of id pharma during investment conferences (DVFA, Biotech Investment conferences, Investor Relation conferences), Working with auditors, two successful yearend audits,1998, 1999.2) Successful closure of financing rounds with venture capital firms (3.1 Mio. € in 1/2000 and 2.4 Mio. € in 8/2000).3) Introduction of a cost center controlling and a lean reporting system.
4) Introduction of a material management system with monthly inventory taking, reduction of inventory losses from 20% in 1999 to 2% in 2000. 5) Improving profitability by outsourcing the warehouse to the pharmacies and by charging cost to pharmacies which were caused by them. |
| Salary: | 82,000 DM, company shares (1,2%), company car |
| Direct reports: | von 6 Angestellten zum Beginn, später von 9 |
Position: CFO
Project details
Company: id pharma Jena GmbH
Timeframe: July 1999 to April 2001
